CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 155 enrolled
Drug / intervention
Zolpidem +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04468776
NCT04468776Phase 4Completed

Comparative Effectiveness of Zolpidem/Trazodone and Cognitive Behavioral Therapy for Insomnia in Rural Adults

California Pacific Medical Center Research Institute·interventional·Posted Jul 13, 2020·Updated Feb 24, 2025

In Brief

A Phase 4 clinical trial evaluating Zolpidem, Internet Cognitive Behavioral Therapy for Insomnia (CBT-I), and 1 other intervention for Chronic Insomnia. Completed, enrolled 155 participants across 7 sites.

Detailed Summary

This study is a randomized (1:1:1) comparative effectiveness trial of medication (zolpidem or trazodone), cognitive-behavioral therapy for insomnia (CBT-I), and the combination (medication + CBT-I) for the treatment of chronic insomnia in men and women aged 18-80 living in rural areas with 1 year of follow-up. A total of 155 participants will be enrolled and randomized in the United States. This trial is funded by the Patient-Centered Outcomes Research Institute.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
202120222023202420252026
First PostedJul 13, 2020
Enrollment StartFeb 25, 2022
Primary CompletionJun 30, 2024
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 6.0 years ago

Interventions

Zolpidemdrug

Zolpidem, as prescribed by physician

Internet Cognitive Behavioral Therapy for Insomnia (CBT-I)behavioral

6-week internet CBT-I multi-component intervention (SHUTi) including sleep restriction, stimulus control, cognitive restructuring, sleep behaviors, and relapse prevention

Trazodonedrug

Trazodone, as prescribed by physician